Literature DB >> 1965126

Loss of antibodies against hepatitis C virus in HIV-seropositive intravenous drug users.

E Chamot1, B Hirschel, J Wintsch, C F Robert, V Gabriel, J J Déglon, S Yerly, L Perrin.   

Abstract

A time-point survey of 262 ex-intravenous drug users (IVDUs) on methadone treatment showed serological evidence of hepatitis C virus (HCV) in 64%, hepatitis B virus in 74% and HIV in 36%. Analysis of previously collected frozen stored sera of the same patients showed that 31 further IVDUs had had anti-HCV antibodies in the past and had lost them in a time-dependent fashion. Most HCV seroreversion was detected in HIV-positive people: 20 out of 85 in the HIV-positive group versus 11 out of 18 in the HIV-negative group.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1965126     DOI： 10.1097/00002030-199012000-00016

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


  24 in total

1.  Significance of indeterminate reactivity to human T-cell lymphotropic virus in western blot analysis of individuals at risk.

Authors:  F J Medrano; V Soriano; E J Calderón; C Rey; M Gutiérrez; R Bravo; M Leal; J González-Lahoz; E Lissen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-03       Impact factor: 3.267

2.  Screening for hepatitis C virus in human immunodeficiency virus-infected individuals.

Authors:  C L Thio; K R Nolt; J Astemborski; D Vlahov; K E Nelson; D L Thomas
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  Hepatitis C virus infection in a large cohort of homosexually active men: independent associations with HIV-1 infection and injecting drug use but not sexual behaviour.

Authors:  N J Bodsworth; P Cunningham; J Kaldor; B Donovan
Journal:  Genitourin Med       Date:  1996-04

4.  Clinical Monitoring of Chronic Hepatitis C Based on its Natural History and Therapy.

Authors:  Douglas L Nguyen; Ke-Qin Hu
Journal:  N Am J Med Sci (Boston)       Date:  2014

5.  Rapid multiplexed immunoassay for simultaneous serodiagnosis of HIV-1 and coinfections.

Authors:  Michael J Lochhead; Kathryn Todorof; Marie Delaney; Jeffrey T Ives; Charles Greef; Kevin Moll; Keagan Rowley; Kurt Vogel; Chris Myatt; Xing-Quan Zhang; Cathy Logan; Constance Benson; Sharon Reed; Robert T Schooley
Journal:  J Clin Microbiol       Date:  2011-08-24       Impact factor: 5.948

6.  A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam.

Authors:  E J Van Ameijden; J A Van den Hoek; G H Mientjes; R A Coutinho
Journal:  Eur J Epidemiol       Date:  1993-05       Impact factor: 8.082

7.  Hepatitis C Virus Infection in Patients Undergoing Hematopoietic Cell Transplantation in the Era of Direct-Acting Antiviral Agents.

Authors:  Andreas Kyvernitakis; Parag Mahale; Uday R Popat; Ying Jiang; Jeff Hosry; Richard E Champlin; Harrys A Torres
Journal:  Biol Blood Marrow Transplant       Date:  2015-12-19       Impact factor: 5.742

8.  Hepatitis C and HIV-1 coinfection.

Authors:  A H Mohsen; P Easterbrook; C B Taylor; S Norris
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

9.  Hepatitis C virus antibodies in homosexual men and intravenous drug users in Denmark.

Authors:  H Westh; A M Worm; B L Jensen; S Kroon; B Kvinesdal; C M Nielsen; P Wantzin
Journal:  Infection       Date:  1993 Mar-Apr       Impact factor: 3.553

10.  Coinfection of hepatitis B and hepatitis C virus in HIV-infected patients in south India.

Authors:  Shanmugam Saravanan; Vijayakumar Velu; Nagalingeswaran Kumarasamy; Subhadra Nandakumar; Kailapuri Gangatharan Murugavel; Pachamuthu Balakrishnan; Solomon Suniti; Sadras Panchatcharam Thyagarajan
Journal:  World J Gastroenterol       Date:  2007-10-07       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.